Using neoantigens in therapy has shown the opportunity to elicit a powerful T cell mediated immune response. Several therapy candidates are now being investigated both
Author: Bradley Patterson
Bradley Patterson is a writer and editorial contributor at ehealthbenefit.com, covering news and features across the site. Bradley focuses on clear, reader-friendly reporting.
